The Low-Density Lipoprotein Receptor Genotype Is a Significant Determinant of the Rebound in Low-Density Lipoprotein Cholesterol Concentration After Lipoprotein Apheresis Among Patients With Homozygous Familial Hypercholesterolemia

Circulation. 2017 Aug 29;136(9):880-882. doi: 10.1161/CIRCULATIONAHA.117.029435.
No abstract available

Keywords: apheresis; cholesterol; familial hypercholesterolemia; genotype; lipoprotein.

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Biomarkers / blood
  • Blood Component Removal*
  • Cholesterol, LDL / blood*
  • Female
  • Genetic Predisposition to Disease
  • Homozygote*
  • Humans
  • Hyperlipoproteinemia Type II / blood
  • Hyperlipoproteinemia Type II / diagnosis
  • Hyperlipoproteinemia Type II / genetics
  • Hyperlipoproteinemia Type II / therapy*
  • Lipoprotein(a) / blood*
  • Longitudinal Studies
  • Male
  • Middle Aged
  • Mutation*
  • Phenotype
  • Receptors, LDL / genetics*
  • Retrospective Studies
  • Treatment Outcome
  • Young Adult

Substances

  • Biomarkers
  • Cholesterol, LDL
  • LDLR protein, human
  • Lipoprotein(a)
  • Receptors, LDL

Grants and funding